All posts by: Michael Zand

FDA approves first gene therapy for adults with blood cancer – The Week Magazine

New York TimesFDA approves first gene therapy for adults with blood cancerThe Week MagazineThe Food and Drug Administration on Wednesday approved a one-time treatment for lymphoma in adults, only the second time a gene therapy for blood cancer has been… Continue reading

Kite Nabs First Adult CAR-T Approval With Notable Uptick Of Cures … – Xconomy

XconomyKite Nabs First Adult CAR-T Approval With Notable Uptick Of Cures …XconomyFor the second time in two months, remarkable recoveries from desperate cases of cancer have led to early approval of a cutting-edge therapy called CAR-T,City of Hope, … Continue reading

FDA OKs 2nd gene therapy for blood cancer; 1st for adults – WHIO

FDA OKs 2nd gene therapy for blood cancer; 1st for adultsWHIOThe treatment involves removing immune system cells called T cells from a patient, reprogramming them to target and kill cancer cells and giving them back to the patient. It uses the same tec… Continue reading

FDA Approves Axicabtagene Ciloleucel for Non-Hodgkin Lymphoma – OncLive

FDA Approves Axicabtagene Ciloleucel for Non-Hodgkin LymphomaOncLiveThe FDA has approved the CD19-directed CAR T-cell therapy axicabtagene ciloleucel as a treatment for adults with relapsed or refractory non-Hodgkin …and more &raquo… Continue reading

Cutting-edge immunotherapy treatment approved for another deadly cancer – Washington Post

Cutting-edge immunotherapy treatment approved for another deadly cancer – Washington Post